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Abstract
Professor Lars Roberg, the initiator of the Nosocomium Academicum (1708), our first university hospital in Sweden,
claimed that ‘no-one who does not understand surgery is a completely trained doctor’. However, it was not until the end of
19th century that modern surgery was born.
The Academic Hospital was opened in 1867, and at the turn of that century Uppsala had a flourishing period under the
influence of Karl Gustav Lennander, professor of surgery. In 1889 he performed the first appendectomy in Scandinavia.
At the end of the 19th century the surgical tree began to branch out. In Uppsala gynaecology and obstetrics was the first to
be an independent speciality (1891). It was followed by ophthalmology (1894) with Allvar Gullstrand as professor and head
of the department. Gullstrand received the Nobel Prize in medicine in 1911. A separate department for diseases of the ear,
nose, and throat was founded in 1916 with the Nobel laureate Robert Ba ´ra ´ny as head.
Thoracic surgery began in Uppsala in the 1940s with lung surgery and was separated from general surgery in 1958 with
Viking Olov Bjo ¨rk as head of the department. Bjo ¨rk introduced open heart surgery in Uppsala.
In 1951 reconstructive plastic surgery was organized by Tord Skoog, who devoted special interest to operations for cleft lip
and palate surgery.
Neurosurgery was established in 1962, and Uppsala has held a prominent position in the development of modern
neurointensive care.
During the 1970s general surgery became subspecialized into gastrointestinal, endocrine, and vascular surgery. At the same
time fracture surgery was transferred to the orthopaedists, and urological surgery became an independent speciality.
Transplantation surgery was introduced in Uppsala in 1967, when Professor Lars Thore ´n performed the first kidney
transplantation. Today Uppsala has a leading position in transplantation of pancreatic islets cells.
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Introduction
For many centuries surgery was regarded as pure
craftsmanship, but during the 18th century the
position of surgery in the medical sphere came to
be increasingly recognized. In Uppsala the professor
of medicine Lars Roberg, initiator of the Nosoco-
mium Academicum (1708), claimed that ‘no-one
who does not understand surgery is a completely
trained doctor’. During the later part of the 19th
century surgery was still looked upon as an ‘external
activity’, and it was not until the end of that century
that modern surgery was born, that is, just over 100
years ago. This was largely made possible by the
fact that at that time the three great enemies of
surgery, namely haemorrhage, pain, and infection,
began to be overcome.
Pioneer operations in Uppsala at the end
of the 19th century
Anaesthesia and asepsis came to create possibilities
for the ‘first great development’ of surgery, which
took place during the last decades of the 19th
century. This applied particularly to abdominal
surgery. The Academic Hospital (Figure 1) was
opened in 1867, and at the turn of that century
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the influence of Karl Gustav Lennander, professor of
surgery. He performed the first appendectomy in
Scandinavia in 1889, when he saved the life of a 28-
year-old male student with a gangrenous appendici-
tis. Lennander was also the first in Sweden to
undertake gastrectomy for cancer (1884), cholecys-
tectomy (1889), and gastroenterostomy for peptic
ulcer (1891). Lennander is also known for his
‘pioneer’ neurosurgical operation in 1897, when in
a young man he removed a foreign body (a pistol
bullet) from the occipital lobe of the brain after
localizing it by X-ray examination (Figure 2).
With the development of surgery at the end of
the 19th century, the surgical tree began to branch
out. In Uppsala gynaecology and obstetrics was the
first to break loose as an independent speciality, and
this was given its own professorship in 1891, with A.
O. Lindfors as the first holder. He was a skilful
surgeon, and during his professorial period in
Uppsala he performed no fewer than 17 caesarean
sections, including one for eclampsia. At that time
eclampsia was not considered to be a condition that
should be treated by caesarean section, but Lindfors
saw the possibility, and with his intervention three
lives were saved*the mother and her twin offspring.
The obstetric department later came to contribute
with notable discoveries in reproduction research,
and the years 1960 75 with Carl Gemzell as
professor can well be said to have been days of glory
for the department.
Ophthalmology branched off early from the
surgical tree
In Uppsala ophthalmiatrics became an indepen-
dent ‘surgical speciality’ at an early date. It was
given its own professorship in 1894, with Allvar
Gullstrand as professor. A Nobel laureate in 1911,
Figure 1. The Academic Hospital in Uppsala. The original building. Photo: Academic Hospital.
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the eye; his innovative concepts of refraction of
light in the eye were pioneering in ophthalmology,
and Gullstrand must be regarded as one of the
foremost scientists in our history of research. The
eye clinic later came to devote considerable clinical
and scientific activity to questions of the wide-
spread diseases cataract and glaucoma, and the
advances in this field were to a great extent a
result of collaboration between preclinical and
clinical researchers. The importance of Uppsala
scientists for the development of cataract surgery
must be especially pointed out here, parti-
cularly the significant contributions made by
Torvard Laurent together with the Hungarian
physician Endre Balazs to the introduction of
hyaluronan in ophthalmic surgery. In co-operation
with Pharmacia, hyaluronan came to be introduced
under the name Healon†. This and other viscoe-
lastic substances are now used worldwide in all
cataract surgery. In the year 2005, at the Uni-
versity Hospital 1,500 cataract operations were
performed, and in the whole of Sweden over
70,000. These operations are performed to-
day under local anaesthesia and take about
30 minutes in uncomplicated cases. The visual
function is improved in over 90% after surgery.
Surgery for hearing improvement
A separate department for diseases of the ear, nose,
and throat was founded in Uppsala in the beginning
of the 20th century, to be exact in 1916. The head of
the department was the Nobel laureate Robert
Ba ´ra ´ny. At first the department was located in
what is nowadays called Slottska ¨llan, formerly an
establishment for hydrotherapy. Here there were
12 beds, an operating theatre, and a laboratory. It
was not until 1925 that the department moved to the
present University Hospital. The Department of
Otolaryngology was a centre for otoneurological
research even during Ba ´ra ´ny’s time, and later under
the leadership of Hans Engstro ¨m (1968 79) success-
ful internal ear research was carried out there. Great
interest was devoted to Menie `re’s disease by Jan
Stahle and his collaborators in the 1970s to 1980s.
At the end of the 1980s, so-called reconstructive
middle ear surgery was developed in Uppsala, and
the University Hospital became an important refer-
ral centre for a large part of the country. The aim
of the surgical operations was to restore sound-
transmitting parts of the external and middle ear
that had been damaged by infections (chronic otitis)
or congenital defects. New surgical principles and
techniques were developed (tympanoplasty) with the
aim of restoring the auditory ossicles and the
tympanic membrane. During the same period sur-
gery for acoustic neurinoma (e.g. vestibular schwan-
noma) was also developed. By surgical removal of
the tumours via the ear, it was possible to avoid
having to move aside the cerebellum, something that
was hazardous and not seldom gave rise to serious
complications; in particular there was a risk of
damaging the facial nerve. This is the current
method today, and the operation is always carried
out in collaboration with neurosurgeons. Uppsala
today is a national centre for this type of activity.
The development of brainstem and cochlear
implantation has revolutionized the treatment of
deafness. As early as in 1993 the first patient in
northern Europe to receive a brainstem implant
underwent this operation in Uppsala, and cochlear
implantation surgery was developed in the present
century. The difference from brainstem implantation
is that in this form of surgery the electrode plate is
inserted surgically into the cochlea instead of on the
brainstem (nucleus cochlearis).
Thoracic surgery is developed and the modern
coronary vascular surgery is introduced
Thoracic surgery began in the 1940s with lung
surgery, which was made possible by the introduction
Figure 2. Professor Karl Gustav Lennander in 1897, removing a
pistol bullet from the occipital lobe of the brain in a young man
after the foreign body had been localized by X-ray. Photo: Medical
Historical Museum, Uppsala.
4 H. Johanssonof the ventilator and intubation anaesthesia. It was
mainly pulmonary tuberculosis that was treated. The
first cardiosurgical operations consisted of closed
commissurotomies in mitral stenosis, a disease which
was usually a consequence of rheumatic fever. Simple
congenital heart defects, especially defects of the
atrial septum, could be operated on under moderate
hypothermia without the help of a heart-lung ma-
chine. The first successful operation with the heart-
lung machine was carried out in the USA in 1953,
and in the following year the second one was
successfully performed by Clarence Crafoord and
collaborators at Sabbatsberg Hospital in Stockholm.
The development of extracorporeal circulation
proceeded rapidly after these successes, but the
surgical treatment ofcoronary arterydisease*bypass
surgery*started at a later stage.
Thoracic surgery at the University Hospital was
initiated at the beginning of the 1950s by Paul
Rudstro ¨m at the Department of Surgery. At that
time it was mostly a matter of lung surgery.
Gradually thoracic surgery came to be separated
from general surgery, and in 1958 it was given an
independent position with the dynamic Viking Olov
Bjo ¨rk as head. Bjo ¨rk, who was one of Crafoord’s
pupils, continued with lung surgery, but most of all
he came to develop open heart surgery in Uppsala.
Together with Martin Holmdahl and the anaesthe-
siologists he also developed the method of deep
hypothermia which was introduced after experimen-
tal trials in dogs. With deep hypothermia operations
could be performed on the open heart, and in
Uppsala this technique was used in a large number
of patients.
During Bjo ¨rk’s ‘Uppsala period’ heart valve
surgery acquired a prominent position. Bjo ¨rk was
one of the early surgeons to use ball valves for
replacement of damaged valves, but he made his
great contribution in this field when later, together
with an American engineer, he came to construct the
Shiley-Bjo ¨rk prosthesis, a prosthesis with a disc
design. This became widely accepted, and during
the end of the 1970s and the beginning of the 1980s
it was the most frequently used prosthetic valve in
the world.
After eight years in Uppsala Bjo ¨rk left our
hospital to succeed Crafoord as professor in Stock-
holm. Even if Bjo ¨rk was only here for a relatively
short time, that time must be regarded as a success-
ful period in the history of the hospital.
Gradually patients with coronary sclerosis be-
came predominant, and increased knowledge was
gained about the relation of this sclerosis to cardiac
infarction and angina pectoris. In Uppsala it was
mainly Lennart Johansson, another Crafoord pupil
and Bjo ¨rk’s successor, who introduced the modern
coronary vascular surgery at the hospital. At the end
of the 1970s the need for this surgery increased
explosively, and the University Hospital held the
responsibility for the whole of northern Sweden, that
is, from Uppsala to Treriksro ¨set, with a catchment
population of 2.5 million.
The original surgical treatment of arrhythmia
consisted of pacemaker therapy. Today a large
number of patients are treated with implanted
defibrillators (ICD), and the use of biventricular
pacemakers in certain forms of heart failure is
another prominent example of the development.
Surgical treatment of atrial fibrillation with the so-
called Maze operation was carried out at an early
date in Uppsala, which today has the largest number
of patients in this field, with good results through-
out. One development here is the use of pulmonary
vein ablation, which can either complement other
cardiac surgery or be conducted independently with
a minimally invasive technique (so-called mini-
Maze).
Reconstructive plastic surgery
The demand for reconstructive surgery first became
clearly evident during the First World War, in 1914 
18. The war in the trenches on the western front, for
example, resulted in a countless number of severe
gunshot and blast injuries to the face in young
soldiers, which required specialized treatment. This
came to form the embryo of plastic surgery. The
development of this new speciality continued during
the interwar period, but it was not until the mid-
1940s that the first department of plastic surgery was
established in our country. This was at the Serafimer
Hospital in Stockholm.
In Uppsala plastic surgery became an indepen-
dent speciality just a few years later. It was estab-
lished on the initiative of the Uppsala surgeon Tord
Skoog (Figure 3), who after training in Finland,
England, and the USA organized a special depart-
ment for plastic surgery in 1951. Skoog was a
‘surgical artist’, and his activity acquired interna-
tional proportions. In 1960 Skoog also became the
first professor in plastic surgery in Sweden. An area
in which he came to devote special interest was the
reconstructive surgery required for repair of cleft lip
and palate in children.
Cleft lip and palate surgery*an Uppsala model
The artistic element in the plastic surgical treatment
of cleft lip and palate came to light when Skoog
together with his collaborators described their own
Uppsala University Hospital 300 years 5refined techniques for use in children with such
malformations. These techniques became widely
accepted both nationally and internationally. At the
same time it became clear that the treatment of facial
deformities requires well developed collaboration
between several specialities. Such a collaborative
treatment programme for children with these mal-
formations was initiated in Uppsala in the mid-
1950s and is still used by the team that takes care of
children with cleft lip and palate and other facial
deformities.
With the availability of refined methods for
plastic surgery of the lip and nose in children with
cleft lip and palate, the need for improved recon-
structions of the jaw gradually became evident. The
treatment of a cleft malformation involves a series of
operations during the whole of childhood and
adolescence. At first reconstruction of the cleft in
the palate often resulted in incomplete closure, and a
breakthrough in the treatment of this cleft was
therefore achieved when it became possible to fill
the defect with a graft of spongy bone with its
surrounding periosteum. With this procedure com-
plete coverage of the palate cleft was achieved. Today
this is the absolutely predominant method for
complete jaw reconstruction in facial malformations.
Skoog was also behind the initiative of the
department of plastic surgery in allowing scope for
the increasing care of burns. Previously burns injury
patients had been treated within the frame of the
department of surgery. The new department was the
first in the country to organize holistic treatment of
burns; that is, the patient was given intensive care
concomitantly with rehabilitative measures. During
the subsequent decades, under the leadership of
Go ¨sta Artursson, the majority of the principles*
including operating at an early stage*that are still
applied today in the treatment of patients with burns
were established. Today Uppsala is one of our two
burns centres*Linko ¨ping is the other.
Uppsala acquires a department of
neurosurgery
The development of neurosurgery in Sweden began
in the early 1920s at the Serafimer Hospital
in Stockholm, under the leadership of Herbert
Olivecrona. In Uppsala a professorship in neurosur-
gery was established in 1962 with Einar Bohm,
educated in Stockholm, in the Chair. The new
department was located in ‘the old lung clinic’.
Broad neurosurgical activity was built up and
included the principal areas of tumour surgery
(brain and spinal cord tumours), traumatology
(treatment of injuries to the brain, spinal cord, and
nerves), vascular surgery (treatment of arterial
aneurysms and vascular malformations), and func-
tional neurosurgery (pain surgery, surgery for epi-
lepsy, and stereotaxy). In 1974 the department
moved to the premises which are used today for
neurosurgical activity.
Uppsala has held a prominent position in the
development of modern neurointensive care. It was
Urban Ponte ´n who in the beginning of the 1980s
introduced the use of intracranial pressure recording
and long-term respirator treatment of unconscious
patients to prevent the development of secondary
brain damage*a therapeutic method that was devel-
oped in close collaboration with colleagues at the
department of anaesthesiology.
Uppsala was given Sweden’s first real depart-
ment of neurointensive care (NIVA) in 1990. The
modern intensive care came to play a major role in
the great expansion of neurosurgery in the 1990s,
which for Uppsala meant that neurosurgery came to
account for a large proportion of the national and
regional medical care undertaken by the University
Hospital. An intracerebral microdialysis technique
for chemical monitoring of some essential metabo-
lites of the brain was introduced in 1992*the first in
the world*which meant a breakthrough for the
Figure 3. Tord Skoog, professor of plastic surgery in Uppsala
1951 77. Photo: Department of Surgical Sciences, Plastic Sur-
gery, University Hospital, Uppsala.
6 H. Johanssonmethod and for neurointensive care, and gave
Uppsala a leading position internationally. Standar-
dized care and computerized surveillance have
meant that the treatment results have progressively
improved. Today about 600 patients receive care at
NIVA every year. The most common conditions
treated are head and spinal cord injuries (circa 35%)
and haemorrhages in the nervous system (circa
35%).
Further subspecialization of general surgery
improves the care
During the 1970s in Uppsala, as in many other
places in Sweden, the surgical activity became
subspecialized, as a consequence of the accelerated
development that had occurred in the medical
sphere. Gastrointestinal surgery, endocrine surgery,
and vascular surgery developed as separate areas
within general surgery. It was no longer possible for
surgeons to master ‘everything’. The surgeon be-
came part of a team, and since that time the
subspecialization has continued and will most cer-
tainly become even more pronounced in the future.
At approximately the same time as these changes
took place, fracture surgery in Uppsala, which
constituted a large part of the general surgeon’s
daily work, was transferred to the orthopaedist, and
urological surgery became an independent speciality.
The last fracture operation*nailing of a femoral
fracture*in the surgical department was performed
a few days after the department had moved its
activities to the present ‘surgical block’, in 1970.
The patient was included, so to speak, in the move.
Gastrointestinal surgery*a speciality with an explosive
development
The development in gastrointestinal surgery has
been almost explosive in the last twenty years with
the introduction of laparoscopic surgery. When this
technique began to be used in the early 1990s*at
first in cholecystectomy for gallstones*Uppsala was
one of the hospitals that introduced the method for
routine practice, and today the laparoscopic techni-
que is applied in many areas in abdominal surgery.
The part of gastrointestinal surgery that first
became dissociated as a separate identity in Uppsala
was the treatment of inflammatory intestinal diseases
(ulcerative colitis and Crohn’s disease). Major pio-
neering work was carried out in this area by Urban
Krause, who built up a ‘centre of excellence’ to take
care of these severely ill patients. This development
became an embryo for the division of gastrointestinal
surgery that we see today, where colorectal diseases
are treated by one team and diseases of the upper
gastrointestinal tract, liver, and pancreas by another.
This separation was carried out in the early years in
Uppsala and is found today in virtually all hospitals
in Sweden.
It is now several decades since Uppsala began to
show interest in surgery for obesity. In close colla-
boration with the geriatric department, nutritional
studies were undertaken on patients with severe
overweight who were offered surgical therapy. The
pioneer in this field was Professor Lars Thore ´n
(Figure 4), who at the beginning of the 1970s
introduced intestinal shunt surgery*jejunoileal by-
pass*in Uppsala. Gradually this method for surgical
treatment of overweight has been abandoned, mainly
for reasons of late metabolic disturbances. As an
alternative, different surgical techniques for decreas-
ing the size of the stomach and achieving an early
feeling of satiety have been developed, and the
method most often used today is gastric bypass. In
Uppsala important metabolic research has been
carried out for this group of patients, and also the
laparoscopic technique was adopted at an early stage
for performing reconstructions of this type.
During the last twenty years of the 20th century
the treatment of rectal cancer was revolutionized.
The introduction of adjunctive treatment with
irradiation and of a new, more exact surgical
technique has led to an improvement of the survival
Figure 4. Lars Thore ´n, professor of surgery in Uppsala 1965 88.
Photo: A ˚ke Andre ´n-Sandberg.
Uppsala University Hospital 300 years 7of rectal cancer patients. Uppsala has held a leading
position in this field and has initiated several large
randomized studies that have changed the approach
in rectal cancer therapy. The so-called ‘Swedish
radiotherapy model’ that was introduced in the
1980s with 5 Gy for 5 days and surgery in the
following week has been shown to be both an
effective and cost-saving form of treatment. This
radiotherapy model, which was initiated by the
oncologist Sten Graffman in Uppsala, has now met
with great interest all over the world, where it is
referred to as ‘the Swedish model’. Uppsala was also
the first centre in Sweden to apply the modern
surgical technique (total mesorectal excision) in
which an exact dissection in the anatomical plane
is performed in rectal cancer surgery. By operating in
this way and with selective use of irradiation, the risk
of local recurrence is minimized, and it has been
shown in Uppsala that the rate of local recurrence
has decreased from 50% to less than 5% in the last
twenty-year period.
At a pace with the refinement of the surgical
technique, it has become important to gain increased
knowledge of the sphincter function and of anal
incontinence. In this area Uppsala has contributed
to an understanding of how anal continence can be
maintained by different surgical methods. This has
led, among other things, to the introduction of a new
sophisticated technique in which, for example, the
gracilis muscle is transposed from the thigh and
placed as a new closing muscle around the anus. The
muscle function is then controlled with the aid of a
pacemaker. As a further development in this area, a
method of sacral nerve stimulation has been intro-
duced, where the sacral nerves are stimulated with
an electrode in a similar way. The Uppsala surgeons
have contributed to the development of these
surgical techniques.
Endocrine surgery*surgery of tumours with varying
biology and disease courses
In the development of endocrine surgery our own
surgeons and clinical researchers have played a
major role. Contributing to this have been the weight
and breadth that endocrinology has attained in
Uppsala and the strong position that endocrinologi-
cal biochemistry and pathology have held over the
years. Both of these subjects have had admirable
representatives in Professors Leif Wide and Lars
Grimelius. Wide has held a front-line position
internationally in the development of various hor-
mone analyses, and Grimelius’s silver staining tech-
nique (published in 1968) is still the most useful
for discriminating between an endocrine and a
‘non-endocrine’ tumour. It is used today at all
histopathological laboratories working with endo-
crine pathology. Close co-operation with other
disciplines has also been a prerequisite for the
practice of endocrine surgery, and there has been
well developed team- work between endocrinolo-
gists, radiologists, and oncologists. In Uppsala para-
thyroid surgery and surgery of endocrine abdominal
tumours, in particular, have held prominent places,
both nationally and internationally.
The parathyroid gland is somewhat of an
‘Uppsala’ organ. It was the Uppsala anatomist Ivar
Sandstro ¨m who discovered these glands in man in
1877, and he published his findings in The Proceed-
ings of Uppsala La ¨karfo ¨reningen in 1880. A hundred
years later another unique study, by Go ¨ran A ˚ker-
stro ¨m, was published from the department of
surgery in Uppsala, on the anatomy and histology
of the parathyroids. Hyperparathyroidism has been a
comprehensive subject of clinical and experimental
studies. The natural course of the disease has been
mapped, and it has been shown that the increased
mortality associated with hypercalcaemia and
caused, in particular, by cardiovascular diseases
can be reduced by successful surgery. In one
interesting study it was found that no fewer than
65% 80% of patients with hyperfunctioning para-
thyroid glands had psychiatric symptoms and that
these problems could be eliminated by surgical
treatment. In some recently published studies it
has been demonstrated that primary hyperparathyr-
oidism, even in a mild form, is associated with
disturbances of both the lipid and skeletal metabo-
lism, and that these are largely eliminated by surgery.
In the research on the pathogenesis of hyperpar-
athyroidism, several important discoveries have been
made here in Uppsala. It has been demonstrated, for
example, that defective calcium regulation can be
due to reduced expression of calcium receptors in
the parathyroid cell. In addition, the research has
shown that the disease can also be caused by a gene
variant that lowers the expression of vitamin D
receptors and thereby decreases the regulatory effect
of the vitamin on the hormone secretion by the
parathyroid glands, and growth. Another interesting
observation is that the parathyroids possess an
enzyme that can convert vitamin D to its active
metabolite and hence regulate growth and hormone
production. Benign tumours of the parathyroids*
adenomas*show increased expression of this en-
zyme and thus inhibited growth, whereas cancers
have reduced expression and thereby aggressive
growth. This observation has pointed to the possi-
bilities of treating malignant tumours in the para-
thyroid gland with vitamin D analogues.
8 H. JohanssonTreatment of endocrine abdominal tumours is a
national speciality of the Uppsala University Hospi-
tal. Moreover many patients come from abroad.
Most patients are treated in collaboration between
the oncoendocrinological clinic and the section of
endocrine surgery. In Uppsala a surgical technique
has been developed which makes it possible to
operate on patients with large pancreatic tumours,
even those with invasive growth into central abdom-
inal vessels. In combination with effective cytostatic
therapy, this has resulted in good survival and a good
quality of life. Patients with multiple endocrine
neoplasia (MEN), a hereditary syndrome with a
dominant trait, often have several tumours conco-
mitantly. Here it is important to determine whether
the tumours are benign or malignant in order to plan
the extent of the surgery. In genetic studies in
Uppsala, mutations and chromosome losses that
are typical of malignant tumours but are not
observed in benign ones have been demonstrated.
Studies in Uppsala have also shown that MEN
patients should be operated on at an early stage to
reduce the risk of tumour growth and metastasis.
Carcinoid of the small intestine, so-called mid-
gut carcinoid, is a different form of tumour, which
has received great interest in Uppsala, both clinically
and in research. This form of tumour often gives rise
to a difficult carcinoid syndrome with flush, diar-
rhoea, and connective tissue transformation of the
heart valves. Lymph node and liver metastases are
common. The regional lymph node metastases have
a tendency to grow around the blood vessels
supplying the small intestine, causing circulatory
disturbances with severe abdominal anginal symp-
toms. In Uppsala this condition has been thoroughly
investigated, and a surgical technique has been
developed whereby the lymph node metastases can
be removed and at the same time the vessels can be
dissected free, allowing preservation of an intact
circulation to the intestine. By this means the
patients can also be relieved of disabling symptoms.
For liver metastases so-called radio wave treatment
has been developed, with which the metastases can
be destroyed. The modern treatment in the form of
both surgical and pharmacological therapy has
meant that the survival among patients with malig-
nant carcinoid has now increased considerably*
from previously being approximately one year to
almost ten years today.
Vascular surgery*a relatively young speciality
Vascular surgery is a relatively young branch of the
surgical tree, and for its expansion in the 20th
century, especially in the later half, the developments
in anaesthesiology, intensive care, diagnosis and
pharmacology were prerequisites. The Uppsala pro-
fessor in orthopaedics Tor Hierton had the foresight
to recognize reconstructive vascular surgery as a way
to reduce the risk of amputations, and right up to the
beginning of the 1960s vascular surgery was part of
the orthopaedic activity, after which time it moved to
the department of surgery. In 1992 the first two
professorships in vascular surgery were created in
Sweden, in Uppsala and Malmo ¨. The practical
development has proceeded rapidly, and in Uppsala
the physiological laboratory for vascular diagnosis is
connected to the unit of vascular surgery, an
arrangement which has advantages both for clinical
practice and research, and has been a model for
many other hospitals. Intimate collaboration with
interventional radiologists for the purposes of en-
dovascular treatment of vascular diseases has led to
the creation in Uppsala of one of the first hybrid
operating theatres in this country. To ensure new
generations of vascular surgeons and provide a
guarantee of their education, distance teaching has
been initiated in Uppsala, with participants mainly
from this health care region but also from other
areas. This has become a model for other special-
ities. Regarding research there are several fields that
are well represented, and research of international
repute has been conducted on subjects such as aortic
aneurysm, bowel ischaemia, vascular epidemiology,
and prophylactic treatment of thromboembolism. In
these areas the vascular surgeons in Uppsala are in
the front line of research.
Transplantation surgery is added
Transplantation surgery was introduced in Uppsala
in 1967. It was in that year that Lars Thore ´n carried
out the first kidney transplantation*three years after
Professor Franksson in Stockholm had performed
the first kidney transplantation in our country. For
the last fifteen years there has also been a liver
transplantation programme, which initially was con-
ducted together with Huddinge Hospital but which
Uppsala now runs under its own management.
The treatment of type 1 diabetes has made great
progress in the last decades. In parallel with other
forms of treatment of this disease, attempts have
been made in the last forty years to transplant the
pancreas. Such transplantations have been carried
out in Sweden since 1974 and are an established
form of treatment, which in combination with
kidney transplantation has been found to improve
the patients’ chances of survival. But it is a relatively
large surgical procedure and not seldom leads to
complications in the postoperative care. In recent
Uppsala University Hospital 300 years 9years, therefore, fewer than ten combined transplan-
tations of the kidney and pancreas per year have
been carried out in Sweden.
Transplantation of islets of Langerhans
Transplantation of islets of Langerhans, the endo-
crine parts of the pancreas, has always been con-
sidered an attractive possibility. The islets of
Langerhans constitute only a small proportion of
the pancreatic tissue but account for the entire
production of insulin. Experimentally, techniques
for islet cell transplantation were developed as early
as in the 1960s, but it was not until the 1980s
that the method gained clinical application. In our
country, Uppsala has stood for the clinical develop-
ment of this form of transplantation. Various tech-
niques have been tried during the years, but for a
long time the results were disappointing.
Unstable and refractory diabetes with frequent
hypoglycaemias, often combined with absence of
warning signals, has been the main target of islet
cell transplantation. A standard has been devel-
oped in which the islets are introduced into the
portal vein via a catheter. The islets then remain
in the liver as small, fragile thrombi in the portal
vein branches. The procedure can usually be
carried out under local anaesthesia. After a few
weeks the blood circulation to the islets is estab-
lished through new formation of blood from
hepatic vessels. During this time the patient
receives intensive treatment with insulin*this to
create optimal glucose control, a form of beta-cell
rest, while the transplanted islets of Langerhans
become adapted to their new milieu.
Since the autumn of 2000 Uppsala has been part
of a Scandinavian network for clinical islet cell
transplantation. The idea is that close collaboration
within research and clinical application will lead to
the attainment of a higher degree of efficacy after the
transplantations. The patients’ insulin production
often corresponds, despite repeated transplanta-
tions, to no more than 25% 40% of the normal
production. The reason for this is that the islets are
subjected to a very rapid and deleterious thrombotic/
inflammatory process, and as a result a large
proportion of the transplanted islets are damaged
and die. At present clinical studies are in progress to
evaluate different strategies aimed at minimizing or
completely blocking this reaction. The end goal stays
firm: to attain a ‘normal’ insulin production as a
regular result after a transplantation of islets of
Langerhans.
Fracture surgery*Uppsala surgery in focus
At the beginning of the 1970s Uppsala came to be
somewhat of a national centre for modern fracture
surgery. The man behind the modernization of
fracture surgery in Sweden was Sven Olerud, then
professor of orthopaedics in Uppsala. He had
developed his interest in fracture surgery in the
1960s and subsequently took his activity to the
department of orthopaedics when the treatment of
fractures was transferred there. Among other meth-
ods Olerud introduced the AO technique, a Swiss
method based on exact fracture reduction and stable
internal fixation. Olerud and his collaborators be-
came experts in ‘repairing’ difficult fractures, not
least fractures of the pelvis and acetabulum. In
several studies it was shown that this technique
had clear advantages over the more conservative
methods, which usually required a long period of
plaster cast fixation. The modern technique, on the
other hand, allowed immediate mobility training
with quicker functional rehabilitation, which meant
considerable advantages for the patient. There was
no doubt that Uppsala came to be of great impor-
tance for the development of traumatology in our
country. Contributing strongly to this was the
driving force of the professor of surgery Lars Thore ´n
in developing the modern fluid and nutritional
therapy. Thore ´n’s scientific contributions in the field
of shock and fluid balance and his wide knowledge in
these areas were also evident in his text-book on fluid
balance, which became the source of information
that was consulted in daily practice.
Urology becomes an independent speciality
In Uppsala urological surgery became an indepen-
dent speciality in 1974 with A ˚ke Fritjofsson as head
of the department. The main interest clinically and
scientifically for the urologists has concerned ques-
tions about urinary bladder cancer and prostate
cancer. The value of radical prostatectomy has
been studied in a Scandinavian trial, where men
with localized prostate cancer were randomized
between radical prostatectomy and watchful waiting.
It was the first study to show a survival benefit for
men with prostate cancer treated with radical
prostatectomy. In on-going studies of that cohort
the quality of life outcomes of the choice of treat-
ment strategy for men with localized prostate cancer
are evaluated. In collaboration with the clinical
chemist Gunnar Ronquist great attention has been
paid to studying the role of prostasomes for the
development of prostate cancer.
10 H. JohanssonGeneral reflections
Surgery is and has always been dependent on
different technological advances and on the devel-
opment in other medical disciplines. For instance,
improved knowledge in ultrasound and video tech-
niques and the introduction of new instruments and
implants have contributed to the development of
surgery in the direction of ‘minimally invasive
interventions’ in many fields. As a result the use of
major open surgery has to a large extent decreased.
Bypass operations have been largely replaced by
balloon dilatations, and abdominal aortic aneurysms
can be treated by application of prostheses with an
endoscopic technique. Stenoses of different kinds
can often be treated to advantage with stents that are
introduced with radiological aid. At the same time
surgery has become more organ-sparing and func-
tionally adapted. Examples of this development are
the breast-saving technique in breast cancer, sparing
of the sphincter in rectal cancer, and preservation of
the stomach in gastric ulcer. Nevertheless the radical
‘major surgery’ still exists and in some cases is
necessary in the treatment of malignant tumour.
Today it is carried out with safer methods and with
better results than before. Moreover surgery is
nowadays performed on increasingly older patients,
and again in these older age groups very good results
are achieved.
One of the great men of surgery, Theodor
Billroth, is said to have stated at the end of the
19th century that the surgeon who goes in for
operating on the heart has lost the respect of his
colleagues for ever. Billroth could not have dreamed
that a hundred years later we would not only be able
to operate on the heart but would also be able to
transplant it, as well as other organs, and do this with
a high degree of safety and with good results. This
shows how difficult it is to predict the future. It may
be assumed, however, that the territorial boundaries
in medical care will disappear. The care will become
first and foremost focused on the patient, and the
surgeon will increasingly become one person in a
team; further, it is doubtful whether in the future we
will have separate departments of surgery. So when
in a hundred years the University Hospital celebrates
its 400th anniversary, a chronicle of surgical activ-
ities will be quite different from that presented in this
survey.
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